The consortium consists of a number of prestigious institutions from around the world.
Consortium meetings take place in England twice each year.
In this advisory role, the consortium members have made significant contributions to the understanding of this new treatment modality. The consortium members are listed below. Dr. Carl Mansfield University of Washington, Seattle, WA Dr. Mark Phillips University of Gent, Belgium Prof. Wilfred De Neve Dr. Luc Vakaet Prof. Carlos de Wagter Dr. Bart Van Duyse Royal Marsden Hospital, London, UK Prof. The Netherlands Cancer Institute, Amsterdam Dr. Ben Mijnheer Dr. Roel.